NCT05847491

Brief Summary

Prospective, descriptive study to assess latent tuberculosis infection (LTBI) among healthcare worker (HCW) in a tertiary hospital in a low-risk area.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 27, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 6, 2023

Status Verified

April 1, 2023

Enrollment Period

1.1 years

First QC Date

April 27, 2023

Last Update Submit

April 27, 2023

Conditions

Keywords

Latent TuberculosisHealthcare workersIGRA

Outcome Measures

Primary Outcomes (1)

  • Number and percentage of latent tuberculosis diagnosis in healthcare workers

    Patients with positive IGRA/tuberculin test screening and without clinical or radiological features of active Tuberculosis

    1 year

Secondary Outcomes (2)

  • Treatment acceptance for latent tuberculosis

    1 year

  • Treatment completion

    1 year

Other Outcomes (1)

  • Treatment discontinuation

    1 year

Study Arms (1)

Healthcare workers

Clinical evaluation, chest x-ray and Interferon-γ release assay (IGRA). Immunocompromised patients will be submitted to a tuberculin skin test. The patients will be evaluated in two or more separate appointments. In the first appointment, patients will be submitted to clinical evaluation and exam request. In the second appointment the results will be evaluated.

Diagnostic Test: IGRA/Tuberculin skin test

Interventions

All patients will receive: * Clinical evaluation; * Chest x-ray. * IGRA (or tuberculin skin test if immunocompromised) * Therapeutic proposal if eligible

Healthcare workers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Medical staff, nurses, laboratory, cardiopulmonary and radiology technician, operational staff from our hospital working for 3 or more months.

You may qualify if:

  • All HCW from our hospital with risk of exposure, working in our hospital for at least 3 consecutive months
  • Acceptance to participate and signed informed consent form

You may not qualify if:

  • History of previous tuberculosis
  • Active Tuberculosis
  • Refusal to sign the informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Hospitalar do Oeste - Torres Vedras

Torres Vedras, Lisbon District, 2560-295, Portugal

RECRUITING

Related Publications (6)

  • Adams S, Ehrlich R, Baatjies R, van Zyl-Smit RN, Said-Hartley Q, Dawson R, Dheda K. Incidence of occupational latent tuberculosis infection in South African healthcare workers. Eur Respir J. 2015 May;45(5):1364-73. doi: 10.1183/09031936.00138414. Epub 2015 Feb 19.

    PMID: 25700382BACKGROUND
  • Almufty HB, Abdulrahman IS, Merza MA. Latent Tuberculosis Infection among Healthcare Workers in Duhok Province: From Screening to Prophylactic Treatment. Trop Med Infect Dis. 2019 May 23;4(2):85. doi: 10.3390/tropicalmed4020085.

    PMID: 31126022BACKGROUND
  • Apriani L, McAllister S, Sharples K, Alisjahbana B, Ruslami R, Hill PC, Menzies D. Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review. Eur Respir J. 2019 Apr 18;53(4):1801789. doi: 10.1183/13993003.01789-2018. Print 2019 Apr.

    PMID: 30792341BACKGROUND
  • Chen B, Gu H, Wang X, Wang F, Peng Y, Ge E, Upshur R, Dai R, Wei X, Jiang J. Prevalence and determinants of latent tuberculosis infection among frontline tuberculosis healthcare workers in southeastern China: A multilevel analysis by individuals and health facilities. Int J Infect Dis. 2019 Feb;79:26-33. doi: 10.1016/j.ijid.2018.11.010. Epub 2018 Nov 22.

    PMID: 30471404BACKGROUND
  • Costa JC, Silva R, Ferreira J, Nienhaus A. Active tuberculosis among health care workers in Portugal. J Bras Pneumol. 2011 Sep-Oct;37(5):636-45. doi: 10.1590/s1806-37132011000500011. English, Portuguese.

    PMID: 22042396BACKGROUND
  • Park Y, Kim SY, Kim JW, Park MS, Kim YS, Chang J, Kang YA. Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis. PLoS One. 2018 Sep 20;13(9):e0204035. doi: 10.1371/journal.pone.0204035. eCollection 2018.

    PMID: 30235272BACKGROUND

MeSH Terms

Conditions

TuberculosisLatent Tuberculosis

Condition Hierarchy (Ancestors)

Mycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsLatent Infection

Study Officials

  • Carina Rolo Silvestre, MD, MSc

    Centro Hospitalar do Oeste

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2023

First Posted

May 6, 2023

Study Start

September 1, 2022

Primary Completion

September 30, 2023

Study Completion

December 31, 2023

Last Updated

May 6, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

All individual participant data (IPD) that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
After publication.
Access Criteria
By request to the authors.

Locations